Nanophage scaffold technology enhances the brightness and visibility of detection molecules used in diagnostic imaging applications. These nanorod-based platforms improve signal intensity in molecular detection systems, enabling more sensitive and accurate diagnostic results.
Manufactured by
Nanophage Technologies
New Zealand
Nanophage Technologies enhances assay sensitivity by up to 50x using precisely engineered biological nanorods that amplify the signal of antibodies of choice, delivering stronger signals and higher sensitivity for improved performance in immunoassays. Greater sensitivity enables earlier disease detection and better health outcomes.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
NTP Nano Tech Projects SRL
Italy · 3 relevant products
Suzhou Linaxin Biotechnology Co., Ltd.
China · 1 relevant product
Novanta
United States · 1 relevant product
18 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 27 closest product alternatives
NTP Nano Tech Projects SRL · Italy
Digital pathology system enabling remote microscopy and live sample visualization for hospitals, laboratories, and research centers. Supports real-time diagnosis and specialist collaboration via web browser without sample transfer. Features medical-grade optics, LIS integration, end-to-end encryption, and CE-IVD compliance.
Suzhou Linaxin Biotechnology Co., Ltd. · China
An advanced diagnostic system for detecting and characterizing genetic mutations using nanopore technology. Provides real-time molecular analysis capabilities for identifying disease-associated genetic variants. Applicable to cancer screening and inherited disorder diagnostics.
Novanta · United States
Technology platforms engineered to enable earlier disease detection through advanced imaging and diagnostic capabilities. These systems leverage Novanta's core technologies for improved diagnostic accuracy.
24 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products